摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bis (2-hexyl) 2,3,5,6-tetraiodoterephthalate | 156122-81-5

中文名称
——
中文别名
——
英文名称
bis (2-hexyl) 2,3,5,6-tetraiodoterephthalate
英文别名
Bis(2-hexyl) 2,3,5,6-tetraiodoterephthalate;dihexan-2-yl 2,3,5,6-tetraiodobenzene-1,4-dicarboxylate
bis (2-hexyl) 2,3,5,6-tetraiodoterephthalate化学式
CAS
156122-81-5
化学式
C20H26I4O4
mdl
——
分子量
838.042
InChiKey
JZEPPAUMFIOVER-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.7
  • 重原子数:
    28
  • 可旋转键数:
    12
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    Dicaesio carbonate2-溴己烷 、 2,3,5,6-Tetraiodoterephthalate 在 碳酸氢钠 、 Brine 、 Sodium sulfate-III 、 silica 、 乙醚 、 hexanes 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 22.5h, 以Flash column chromatography (silica, 1:19; Et2O: hexanes) provided bis (2-hexyl) 2,3,5,6-tetraiodoterephthalate (0.52 g, 44%) as a light yellow solid的产率得到bis (2-hexyl) 2,3,5,6-tetraiodoterephthalate
    参考文献:
    名称:
    Compositions of iodobenzoic acid derivatives and pharmaceutically
    摘要:
    本发明涉及用于口服或逆行检查胃肠道的X射线造影剂组合物,包括碘苯甲酸衍生物作为X射线产生剂,与医药上可接受的黏土结合在医药上可接受的载体中;以及在胃肠道的诊断放射学中使用它们的方法。
    公开号:
    US05484585A1
点击查看最新优质反应信息

文献信息

  • Compositions of iodobenzoic acid derivatives in film-forming materials
    申请人:Sterling Winthrop Inc.
    公开号:US05312616A1
    公开(公告)日:1994-05-17
    Disclosed are x-ray contrast compositions for oral or retrograde examination of the gastrointestinal tract comprising a polymeric material capable of forming a coating on the gastrointestinal tract and an x-ray producing agent of the formula ##STR1## wherein Z=H, halo, C.sub.1 -C.sub.20 alkyl, cycloalkyl, lower alkoxy, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R=C.sub.1 -C.sub.25 alkyl, cycloalkyl, or halo-lower-alkyl, optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxycarbonyloxy, (CR.sub.1 R.sub.2).sub.p --(CR.sub.3 .dbd.CR.sub.4).sub.m Q, or (CR.sub.1 R.sub.2).sub.p --C.tbd.C--Q; R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are independently lower-alkyl, optionally substituted with halo; x is 1-3 y is 1-4; n is 1-5; m is 1-15; p is 1-10; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl.
    本发明涉及一种用于口服或逆行检查胃肠道的X射线造影剂,包括能够在胃肠道形成涂层的聚合物材料和具有下式的X射线产生剂:##STR1## 其中Z=氢、卤素、C.sub.1-C.sub.20烷基、环烷基、较低的烷氧基、基,其中烷基和环烷基可以用卤素或卤素较低烷基代替;R=C.sub.1-C.sub.25烷基、环烷基或卤素较低烷基,可选地被卤素、较低烷基、芳基、较低烷氧基、羟基、羧基、较低烷氧基羰基或较低烷氧基羰酰氧基取代,(CR.sub.1R.sub.2).sub.p--(CR.sub.3.dbd.CR.sub.4).sub.mQ,或(CR.sub.1R.sub.2).sub.p--C.tbd.C--Q;R.sub.1、R.sub.2、R.sub.3和R.sub.4独立地为较低烷基,可选地被卤素取代;x为1-3,y为1-4;n为1-5;m为1-15;p为1-10;Q为氢、较低烷基、较低烯基、较低炔基、较低烷基、芳基或芳基-较低烷基。
  • Compositions of iodobenzoic acid derivatives for visualization of the
    申请人:Sterling Winthrop Inc.
    公开号:US05344638A1
    公开(公告)日:1994-09-06
    Disclosed are contrast agents of the formula ##STR1## contained in aqueous compositions and methods for their use in diagnostic radiology of the gastrointestinal tract wherein wherein Z=H, halo, C.sub.1 -C.sub.20 alkyl, cycloalkyl, lower alkoxy, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R=C.sub.1 -C.sub.25 alkyl, cycloalkyl, or halo-lower-alkyl, optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy, (CR.sub.1 R.sub.2).sub.p --(CR.sub.3 .dbd.CR.sub.4).sub.m Q, or (CR.sub.1 R.sub.2).sub.p --C.tbd.C--Q; R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are independently lower-alkyl, optionally substituted with halo; x is 1-3 y is 1-4; n is 1-5; m is 1-15; p is 1-10; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl in an aqueous, pharmaceutically acceptable carrier.
    本发明涉及一种公式为##STR1##的造影剂,该造影剂包含在性组合物中,并且用于胃肠道诊断放射学的方法,其中Z=H,卤素,C.sub.1-C.sub.20烷基,环烷基,低烷氧基,基,其中烷基和环烷基可以用卤素或卤素-低烷基基团取代;R=C.sub.1-C.sub.25烷基,环烷基或卤素-低烷基,可选择地用卤素,-低烷基,芳基,低烷氧基,羟基,羧基,低烷氧基羰基或低烷氧基羰基氧基取代,(CR.sub.1R.sub.2).sub.p--(CR.sub.3.dbd.CR.sub.4).sub.mQ,或(CR.sub.1R.sub.2).sub.p--C.tbd.C--Q;R.sub.1,R.sub.2,R.sub.3和R.sub.4独立地为低烷基,可选择地用卤素取代;x为1-3,y为1-4;n为1-5;m为1-15;p为1-10;Q为H,低烷基,低烯基,低炔基,低烷基烯,芳基或芳基-低烷基,在性、药学上可接受的载体中。
  • Composition of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
    申请人:NYCOMED IMAGING AS
    公开号:EP0614668A2
    公开(公告)日:1994-09-14
    Disclosed are contrast agents of the formula or a pharmaceutically acceptable salt thereof, contained in aqueous compositions and methods for their use in diagnostic radiology of the gastrointestinal tract wherein Z = H, halo, C1-C20 alkyl, cycloalkyl, lower alkoxy, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R = C1-C25 alkyl, cycloalkyl, or halo-lower-alkyl, optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy, (CRi R2)p - (CR3 = CR4)mQ, or (CR1 R2)p - C ≡ C - Q ; Ri, R2, R3 and R4 are independently lower-alkyl, optionally substituted with halo; x is 1-3 y is 1-4; n is 1-5; m is 1-15; p is 1-10; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl in an aqueous, pharmaceutically acceptable carrier.
    公开了式中的造影剂 或其药学上可接受的盐、 及其在胃肠道放射诊断中的使用方法 其中 Z = H、卤素、C1-C20 烷基、环烷基、低级烷氧基、基,其中烷基和环烷基可被卤素或卤代低级烷基取代; R = C1-C25 烷基、环烷基或卤代低烷基,可任选被卤、代低烷基、芳基、低烷氧基、羟基、羧基、低烷氧基羰基或低烷氧基羰氧基、(CRi R2)p - (CR3 = CR4)mQ 或 (CR1 R2)p - C ≡ C - Q 取代; Ri、R2、R3 和 R4 独立地为低级烷基,可选择被卤代取代; x 是 1-3 y 是 1-4; n 是 1-5 m 是 1-15; p 是 1-10;以及 Q 是 H、低级烷基、低级烯基、低级炔基、低级亚烷基、芳基或芳基-低级烷基,在性药学可接受载体中。
  • Compositions of iodobenzoic acid derivatives in filmforming materials for visualization of the gastrointestinal tract
    申请人:NYCOMED IMAGING AS
    公开号:EP0614669A2
    公开(公告)日:1994-09-14
    Disclosed are x-ray contrast compositions for oral or retrograde examination of the GI tract comprising a polymeric material capable of forming a coating on the GI tract, said polymeric material having atoms containing polarizable electrons thereon, in combination with a divalent cation; and an x-ray contrast producing agent of the formula wherein Z = H, halo, C1-C20 alkyl, cycloalkyl, lower alkoxy, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R = C1-C25 alkyl, cycloalkyl, or halo-lower-alkyl, optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy, (CR1R2)p - (CR3 = CR4)mQ, or (CR1 R2)p - C ≡ C - Q; Ri, R2, R3 and R4 are independently lower-alkyl, optionally substituted with halo; x is 1-3 y is 1-4; n is 1-5; m is 1-15; p is 1-10; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl; in a pharmaceutically acceptable carrier and a method of its use in diagnostic radiology of the GI tract.
    本发明公开了用于消化道口腔或逆行检查的 X 射线造影剂组合物,该组合物包括一种可在消化道上形成涂层的聚合材料,所述聚合材料上有含有可极化电子的原子,并与二价阳离子结合;以及一种X射线造影剂,其式为 其中 Z = H、卤素、C1-C20 烷基、环烷基、低级烷氧基、基,其中烷基和环烷基可被卤素或卤代低级烷基取代; R = C1-C25 烷基、环烷基或卤代低烷基,可任选被卤、代低烷基、芳基、低烷氧基、羟基、羧基、低烷氧基羰基或低烷氧基羰氧基、(CR1R2)p - (CR3 = CR4)mQ 或 (CR1 R2)p - C ≡ C - Q 取代; Ri、R2、R3 和 R4 独立地是低级烷基,可选择被卤代取代; x 是 1-3 y 是 1-4; n 是 1-5 m 是 1-15; p 是 1-10;以及 Q 是 H、低级烷基、低级烯基、低级炔基、低级亚烷基、芳基或芳基-低级烷基;在药学上可接受的载体中,及其在消化道放射诊断中的使用方法。
  • X-RAY CONTRAST COMPOSITIONS CONTAINING PHARMACEUTICALLY ACCEPTABLE CLAYS
    申请人:NYCOMED IMAGING AS
    公开号:EP0756497A1
    公开(公告)日:1997-02-05
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫